Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Regeneron Pharmaceuticals, Inc. Stock a Buy?

TheMotleyFool

0 0

Is Regeneron Pharmaceuticals, Inc. Stock a Buy?

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) stock has been a huge winner in the past. A $10,000 investment in the biotech 10 years ago would be worth more than $200,000 today. Regeneron's shareholders have been on a roller-coaster ride, though, with the stock plunging in 2016 but bouncing back somewhat this year.

What Regeneron has done in the past isn't nearly as important to investors as what the biotech could do in the future. Is the stock now a buy? Here are the arguments for and against Regeneron.

Image source: Getty Images.

Source: Fool.com